APA aipamena

Muller, J., Bolomsky, A., Dubois, S., Duray, E., Stangelberger, K., Plougonven, E., . . . Caers, J. (2018). Maternal embryonic leucine zipper kinase inhibitor OTSSP167 has preclinical activity in multiple myeloma bone disease. Haematologica.

Chicago Style aipamena

Muller, Joséphine, et al. "Maternal Embryonic Leucine Zipper Kinase Inhibitor OTSSP167 Has Preclinical Activity in Multiple Myeloma Bone Disease." Haematologica 2018.

MLA aipamena

Muller, Joséphine, et al. "Maternal Embryonic Leucine Zipper Kinase Inhibitor OTSSP167 Has Preclinical Activity in Multiple Myeloma Bone Disease." Haematologica 2018.